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Human HCF-1 is a large, highly conserved, and abundant nuclear protein that plays an important but
unknown role in cell proliferation. It also plays a role in activation of herpes simplex virus immediate-early
gene transcription by the viral regulatory protein VP16. A single proline-to-serine substitution in the HCF-1
VP16 interaction domain causes a temperature-induced arrest of cell proliferation in hamster tsBN67 cells and
prevents transcriptional activation by VP16. We show here that HCF-1 is naturally bound to chromatin in
uninfected cells through its VP16 interaction domain. HCF-1 is chromatin bound in tsBN67 cells at permissive
temperature but dissociates from chromatin before tsBN67 cells stop proliferating at the nonpermissive
temperature, suggesting that loss of HCF-1 chromatin association is the primary cause of the temperature-
induced tsBN67 cell proliferation arrest. We propose that the role of HCF-1 in cell proliferation is to regulate
gene transcription by associating with a multiplicity of DNA-bound transcription factors through its VP16
interaction domain.
Regulated cell proliferation requires the coordination of
many distinct cellular processes. Much of this coordination
occurs through the regulation of gene expression, often at the
level of transcription. Consequently, transcriptional regulation
is often altered when cells become oncogenic and manipulated
by viruses to promote infection. For example, the DNA-bound
transcriptional activator E2F and the E2F-associated retino-
blastoma (Rb) transcriptional repressor protein are important
players in the control of cell proliferation and their activities
are often disrupted during oncogenesis and manipulated by
viral regulatory proteins during DNA tumor virus infection
(see references 4 and 22 for reviews). Other less well-under-
stood regulators of cell proliferation include the cellular pro-
tein HCF-1. HCF-1 is a highly conserved and abundant nuclear
protein that plays a known role in herpes simplex virus type 1
(HSV-1) infection (for reviews, see references 10 and 23) and
an important but unknown role in cell proliferation (7).
Many aspects of HCF-1 make it an unusual protein. It is
initially synthesized as a large precursor molecule of over 2,000
amino acids (29). After synthesis, HCF-1 migrates to the nu-
cleus, where it is cleaved repeatedly at a series of six 26-amino-
acid repeats located near the middle of the protein (11, 29, 30).
These cleavages result in a heterogeneous collection of stable
amino (HCF-1N)- and carboxy (HCF-1C)-terminal subunits
that remain noncovalently associated (30). Although the un-
usual maturation process of HCF-1 has been well documented,
how HCF-1 functions normally in the cell is essentially un-
known.
Much more is known about the role of HCF-1 during HSV-1
infection. When HSV-1 first infects a cell, HCF-1 forms a
stable heterodimeric complex with the viral transcriptional reg-
ulator VP16 (also known as Vmw65 and a-TIF), which is
delivered by the infecting virion. Together, the HCF-1–VP16
complex binds to the cellular transcription factor Oct-1 on
DNA to form a multiprotein transcriptional activator com-
plex—the VP16-induced complex—on VP16-responsive ele-
ments found in HSV-1 immediate-early promoters (for re-
views, see references 10 and 23). Although HCF-1 is a large
protein, only the 380 amino-terminal residues of HCF-1 are
necessary to associate with VP16 and promote VP16-induced
complex formation (13, 28). These 380 amino acids contain six
tandem repeats called HCF-1Kel repeats because they are re-
lated to repeats found in the Drosophila protein Kelch (31);
these repeats probably form a stable structure called a b pro-
peller (3, 28) and are collectively referred to, interchangeably,
as the Kelch or VP16 interaction domain.
HCF-1 is known to be involved in cell proliferation because
a single proline-to-serine missense mutation at position 134 in
the VP16 interaction domain (P134S) causes temperature-in-
duced cell proliferation arrest in the hamster cell line tsBN67
(7). tsBN67 cells proliferate normally at the permissive tem-
perature of 33.5°C, but a few cell divisions after transfer to the
nonpermissive temperature of 40°C, these cells enter a stable
cell proliferation arrest. HCF-1 processing and stability are
nearly normal in tsBN67 cells at the nonpermissive tempera-
ture, but association with VP16 is disabled, suggesting that the
arrest phenotype is caused by loss of HCF-1 association with a
cellular protein(s) mimicked by VP16 (7, 28). Although suffi-
cient for formation of the VP16-induced complex, however,
the HCF-1 VP16 interaction domain is not sufficient to rescue
the tsBN67 cell proliferation defect; a neighboring basic region
within the HCF-1N subunit is also required for rescue (28).
Although little is known of how HCF-1 promotes cell pro-
liferation, multiple molecular targets of HCF-1 function have
been inferred from the results of Saccharomyces cerevisiae two-
hybrid and in vitro protein-binding assays. The basic leucine
zipper proteins LZIP (also known as Luman) and Zhangfei
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(ZF) associate with the HCF-1 VP16 interaction domain in
a manner similar to that of VP16 (5, 15–17); all three pro-
teins possess a short tetrapeptide HCF-1-binding motif—
(D/E)HXY (where X denotes a variable position)—and
their association with HCF-1 is sensitive to the tsBN67 point
mutation. Two transcription factors associate with the
HCF-1 basic region: GABP (26) and Sp1 (8). Last, the
HCF-1C subunit can associate with protein phosphatase 1
(1). Although these protein association studies (1, 5, 8,
15–17, 26) suggest that HCF-1 plays a role in transcriptional
regulation, possibly through modulation of protein phos-
phorylation, a natural molecular function of HCF-1 remains
to be elucidated.
We show here that, in uninfected cells, HCF-1 is associated
with chromatin through its VP16 interaction domain. In
tsBN67 cells, HCF-1 dissociates from chromatin preceding
temperature-induced cell proliferation arrest. These results
suggest that HCF-1 plays an active role in cell proliferation
through the regulation of chromosomal gene expression.
MATERIALS AND METHODS
Small-scale biochemical fractionation. Small-scale biochemical fractionation
was performed as described previously (20). Briefly, 1 3 107 to 2 3 107 cells were
collected, washed with phosphate-buffered saline (PBS), and resuspended at 4 3
107 cells/ml in buffer A (10 mM HEPES [pH 7.9], 10 mM KCl, 1.5 mM MgCl2,
0.34 M sucrose, 10% glycerol, 1 mM dithiothreitol, and protease inhibitor cock-
tail [Boehringer]). Triton X-100 was added (0.1% final concentration), the cells
were incubated on ice for 8 min, and nuclei (fraction P1) were collected by
centrifugation (5 min, 1,300 3 g, 4°C). The supernatant (fraction S1) was clari-
fied by high-speed centrifugation (5 min, 20,000 3 g, 4°C), and the supernatant
(fraction S2) was collected. The P1 nuclei were washed once in buffer A and lysed
for 30 min in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM dithiothreitol, and
protease inhibitor cocktail [Boehringer]), and insoluble chromatin (fraction P3)
and soluble (fraction S3) fractions were separated by centrifugation (5 min,
1,700 3 g, 4°C). The P3 fraction was washed once with buffer B and resuspended
either in sodium dodecyl sulfate (SDS)-Laemmli buffer (and boiled for 10 min)
or in nuclease digestion buffer.
MNase treatment. For micrococcal nuclease (MNase) treatment, the P3 pellet
was resuspended in a solution containing 10 mM Tris, 10 mM KCl, and 1 mM
CaCl2 and 1 U of MNase (Sigma) was added. After 37°C incubations for the
times indicated in Fig. 1C, the reaction was stopped with EGTA (1 mM final
concentration). Soluble and insoluble components were then separated by cen-
trifugation (5 min, 1,700 3 g, 4°C). The pellet was resuspended in SDS-Laemmli
buffer and boiled for 10 min. Half of the supernatant was used for immunoblot
analysis, the remainder was extracted with phenol-chloroform and ethanol pre-
cipitated, and its DNA content was analyzed by agarose gel electrophoresis.
Retroviral vectors and stable HCF-1 synthesis. A pBabeFLAG retroviral
expression vector was constructed by inserting oligonucleotides encoding the
FLAG epitope tag (DYKDDDDK) into the pBabe-Puro vector (21). XbaI-
BamHI cDNA fragments encoding either the wild-type human HCF-1N1011 sub-
unit (HCF-1 residues 2 to 1011), its alternative splice variant HCF-1N1011D382–450,
its tsBN67 mutant version HCF-1N1011/P134S, or the VP16 interaction domain
(HCF-1N380) alone were inserted into the pBabeFLAG vector. Populations of
cells stably synthesizing FLAG-tagged forms of HCF-1 were obtained by retro-
viral gene transfer with the Phoenix amphotropic virus packaging line as de-
scribed previously (25). Infected HeLa and IMR90 cells were selected by cul-
turing cells in 10% fetal bovine serum (FBS) in Dulbecco’s modified Eagle’s
medium (DMEM) containing 2 mg of puromycin per ml for 7 to 10 days.
Subpopulations of infected cells were frozen for future use, and others were lysed
and tested for recombinant HCF-1 synthesis by FLAG tag immunoblot analysis.
Cells infected with the pBabeFLAG parent vector were used as controls.
Immunoblot analysis. Polyclonal HCF-1N subunit (aN18 [7]) and HCF-1c
subunit (aH12 [29]) antisera have been described previously. They are referred
to here as aHCF-1N and aHCF-1C, respectively, and were used at a 1:3,000
dilution for immunoblot probing. Anti-FLAG (M2; Sigma) and anti-MEK2
(M24520; Transduction Laboratories) antisera were obtained commercially.
ORC2 and MCM3 antisera were kind gifts of J. Me´ndez and B. Stillman (Cold
Spring Harbor Laboratory). Immunoblots were prepared by semidry transfer and
developed by chemiluminescence (SuperSignal; Pierce).
Immunofluorescence. IMR90 cells were seeded onto sterile coverslips. After
24 h, cells were (i) washed with PBS, (ii) fixed for 20 min with 4% paraformal-
dehyde, (iii) permeabilized for 5 min with 0.1% Triton X-100 in PBS, (iv) washed
twice with PBS, and (v) blocked for 20 min with 5% bovine serum albumin in
PBS. After being rinsed with PBS, coverslips were incubated for 1 h with protein
A-purified aHCF-1N antibody and excess specific (N18) or nonspecific (FLAG)
peptide. The samples were then washed five times with PBS and incubated for
1 h with Texas Red-conjugated secondary antibody. After being extensively
washed with PBS, the coverslips were stained with DAPI (49,69-diamidino-2-
phenylindole) and mounted, and fluorescence was observed with a Zeiss fluo-
rescence microscope.
HCF-1 quantitation. A six-His tag–HCF-1N380 fusion protein was synthesized
to high levels in Escherichia coli and prepared by bacterial lysis with SDS-
Laemmli buffer. The levels of six-His tag–HCF-1N380 fusion protein in the lysate
were determined by SDS-polyacrylamide gel electrophoresis and Coomasie
staining of a twofold serial dilution of the lysate alongside a serial dilution of
bovine serum albumin of known concentration. HeLa or IMR90 cells were
counted and directly lysed in SDS-Laemmli buffer. The levels of HCF-1 were
directly compared to those of the six-His tag–HCF-1N380 fusion protein by
parallel immunoblot analysis with the aHCF-1N antiserum.
BHK21 and tsBN67 cells. BHK21 and original tsBN67 cells were a kind gift of
T. Nishimoto (Kyushu University). The tsBN67 cells were single-cell subcloned
to produce the tsBN67HR1 line used here. tsBN67HR1 cells display the same
temperature-sensitive proliferation defect as the original tsBN67 cells. Cells were
grown in DMEM supplemented with 10% FBS. To measure tsBN67HR1 cell
proliferation arrest at 40°C, 2 3 104 BHK21 or tsBN67HR1 cells were (i) seeded
onto 6-cm-diameter plates, (ii) maintained at 33.5°C for 48 h, and (iii) trans-
ferred to 40°C, and portions were collected every 12 h by trypsinization and
counted with a hemacytometer. To arrest tsBN67 cell proliferation by limiting
serum, asynchronous populations of tsBN67HR1 cells were incubated at 33.5°C
for 24 h in DMEM containing 0.25% FBS and subsequently transferred to 40°C
and harvested at the times indicated in Fig. 7.
RESULTS
HCF-1 associates with chromatin. HCF-1 is a nuclear pro-
tein and, as part of the HSV-1 VP16-induced complex, asso-
ciates with DNA. We therefore asked whether, in uninfected
cells, HCF-1 is associated with DNA in the form of chromatin.
We used a small-scale biochemical fractionation scheme (20)
illustrated in Fig. 1A. HeLa cell lysates prepared with a non-
ionic detergent were divided by sequential centrifugation into
three fractions: (i) a fraction largely consisting of soluble cy-
tosolic components called S2, (ii) a fraction containing soluble
nuclear components called S3, and (iii) an insoluble pellet
fraction containing chromatin and nuclear matrix components
called P3. The S2 fraction probably also contains soluble nu-
clear components owing to permeabilization of the nuclear
membrane by the nonionic detergent.
To verify appropriate fractionation by this procedure, we
probed the three different fractions by immunoblot analysis for
the chromatin-associated DNA replication factor ORC2 and
the cytoplasmic signal transduction kinase MEK2. As shown in
Fig. 1B (lower panels), consistent with the desired fraction-
ation, the majority of the ORC2 protein was in the P3 chro-
matin-containing pellet (compare lanes 1 to 3) whereas the
MEK2 protein was in the S2 cytosolic fraction (compare lanes
4 to 6).
Using the same fractions, we analyzed the distribution of the
native HCF-1N and HCF-1C subunits with HCF-1N and
HCF-1C subunit-specific antisera. The large majority of the
heterogeneous collection of endogenous HCF-1N (lanes 1 to 3)
and HCF-1C (lanes 4 to 6) subunits were recovered in the P3
chromatin-containing pellet (Fig. 1B, upper panels). Similar
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results were obtained with human IMR90 and 293 cells (see
below and data not shown). These results suggest that HCF-1
subunits are attached to chromatin or some other insoluble
structure in the nucleus.
To distinguish between these two possibilities, we treated
the P3 fraction with MNase to solubilize the chromatin. As
shown in Fig. 1C, the majority of the HCF-1 in the P3 fraction
becomes soluble within 2 to 5 min of MNase treatment (lanes
1 to 4, compare the pellet and supernatant panels). This pat-
tern of HCF-1 MNase solubilization parallels that of the chro-
matin-bound DNA replication protein MCM3 (lanes 5 to 8).
Analysis of the DNA in the MNase-treated samples showed
that DNA release from the P3 pellet paralleled HCF-1 solu-
bilization (data not shown). These results indicate that HCF-1
is associated with nuclease-sensitive chromatin in proliferating
tissue culture cells.
The HCF-1C subunit is dispensable for chromatin associa-
tion by the HCF-1N subunit. To map the regions of HCF-1
responsible for directing it to chromatin, we used a retroviral
expression vector to direct synthesis of four epitope-tagged
truncations of HCF-1 in HeLa cells. Figure 2A shows the
overall structure of HCF-1 with the positions of (i) defined
structural regions (e.g., HCF-1Kel repeats and basic region),
(ii) functional regions (e.g., VP16-induced complex formation
and HCF-1 subunit association), and (iii) regions involved in
association with heterologous viral (VP16) and cellular (e.g.,
LZIP, GABP, and PP1) proteins. Figure 2B shows the series of
four FLAG epitope-tagged HCF-1 proteins used to study
HCF-1 recruitment to chromatin. Each of these epitope-
tagged proteins is a derivative of the HCF-1N subunit: (i)
HCF-1N1011 represents the wild-type HCF-1N subunit, (ii)
HCF-1N1011D382–450 represents the product of an alternative
HCF-1 pre-mRNA splice which does to associate with HCF-1C
subunits (30), (iii) HCF-1N1011/P134S carries the tsBN67 P134S
mutation, and (iv) HCF-1N380 represents the VP16 interaction
domain alone.
Figure 2C shows the results of biochemical fractionation of
cells with each FLAG-tagged HCF-1N1011 derivative. The re-
combinant proteins were visualized alone with the aFLAG-tag
antiserum (upper panel) or together with the endogenous pro-
teins with the aHCF-1N subunit antiserum (lower panel). The
aFLAG-tag analysis shows that the HCF-1N1011 protein is re-
covered in the P3 fraction (lanes 4 to 6, upper panels); this
HCF-1N1011 protein could be solubilized by MNase treatment
(data not shown), indicating that it is chromatin bound. The
HCF-1N1011D382–450 protein, which does not associate with the
HCF-1C subunit (30), is also present in the chromatin-contain-
ing P3 fraction (compare lanes 7 to 9, upper panel), indicating
that association with the HCF-1C subunit is dispensable for
chromatin association by the HCF-1N subunit.
Probing with the aHCF-1N antiserum (Fig. 2C, lower gels)
shows that the recombinant HCF-1N proteins are synthesized
at levels similar to those of the endogenous proteins and that
the endogenous HCF-1N subunits are still largely associated
with chromatin (compare lanes 1 to 12). Thus, in these cells the
endogenous HCF-1N proteins are not dislodged from the chro-
matin to any great extent.
The HCF-1 VP16 interaction domain is necessary and suf-
ficient for chromatin association. The HCF-1N subunit con-
tains two functional regions that might be involved in chroma-
tin association: the VP16 interaction domain and the basic
region. Both of these regions are required to rescue the
tsBN67 HCF-1 cell proliferation defect (28) and can associate
with cellular DNA-binding proteins (5, 8, 16, 26). To deter-
mine whether the VP16 interaction domain is required for
HCF-1N–chromatin association, we tested whether the HCF-
FIG. 1. HCF-1 is chromatin associated. (A) Biochemical fraction-
ation scheme (see Materials and Methods for details). Final fractions
used for analysis—S2, S3, and P3—are boxed. (B) HCF-1 is enriched
in the chromatin-containing P3 fraction. HeLa cells were subjected to
biochemical fractionation, and cell-equivalent amounts of fractions S2,
S3, and P3 were probed by immunoblotting with aHCF-1N (upper left
panel), aHCF-1C (upper right panel), aORC2 (lower left panel), and
aMEK2 (lower right panel) antisera. The positions of the heteroge-
neous HCF-1 subunits are indicated by double dots. (C) HCF-1 can be
solubilized in the chromatin-enriched P3 fraction by treatment with
MNase. The P3 fraction was resuspended in nuclease buffer and
treated with MNase (see Materials and Methods) for the times indi-
cated. The digested suspension was then centrifuged, and the super-
natant (upper panel) and pellet (lower panel) were collected and
analyzed by immunoblotting with aHCF-1N (lanes 1 to 4) and aMCM3
(lanes 5 to 8) antisera.
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1N1011/P134S protein, which fails to associate with VP16 (28),
LZIP (5), and ZF (15), associates with chromatin. Indeed, the
HCF-1N1011/P134S subunit failed to associate with chromatin
(Fig. 2C, lanes 10 and 12, upper panel) and did not cofraction-
ate with the endogenous HCF-1N subunits (compare lanes 10
and 12, lower panel). Thus, an HCF-1 point mutation, which is
known to prevent HCF-1 association with proteins that bind
DNA, also prevents HCF-1N association with chromatin. To-
gether with the lack of any evidence that HCF-1 normally
binds DNA directly, these results suggest that HCF-1 is teth-
ered to DNA by interaction with a protein receptor at least in
part through its VP16 interaction domain. Because in this
experiment the HCF-1N1011/P134S mutant protein is present
alongside the chromatin-bound wild-type endogenous protein,
the lack of chromatin-bound HCF-1N1011/P134S protein sug-
gests that HCF-1N subunits do not recruit each other to chro-
matin through higher-order homomeric complex formation.
To test whether the HCF-1 VP16 interaction domain is not
only necessary but also sufficient for HCF-1N–chromatin asso-
ciation, we asked whether the HCF-1N380 fragment (Fig. 2B)
can associate with chromatin. The HCF-1N380 fragment is in-
deed largely present in the P3 fraction (compare lanes 4 to 6).
Thus, the VP16 interaction domain is both necessary and suf-
ficient for HCF-1N–chromatin association. These results sug-
gest that HCF-1N subunits are tethered to DNA in chromatin
through their VP16 interaction domains and that the basic
region is dispensable for HCF-1–chromatin association.
Nuclear localization of HCF-1N1011 but not the
HCF-1N1011/P134S mutant. Given the results of previous studies
of HCF-1 subcellular localization (12, 27), HCF-1N subunit–
chromatin association is paradoxical. The previous studies
have shown that HCF-1 nuclear localization is directed by a
single nuclear localization signal (NLS) located at the carboxy
terminus of HCF-1 (Fig. 2A). When it is synthesized indepen-
dently of the HCF-1C subunit by transient overexpression, the
HCF-1N subunit remains in the cytoplasm (12, 27). How then
is the HCF-1N subunit present in the chromatin-containing P3
fraction after stable synthesis in HeLa cells? We hypothesized
that, if not synthesized at very high levels as during transient
overexpression, the majority of the HCF-1N subunits may be
brought to chromatin and hence the nucleus by the VP16
interaction domain.
To test this hypothesis, we assayed HCF-1N1011 and HCF-
1N1011/P134S localization by immunofluorescence in IMR90
cells carrying the FLAG tag retroviral expression vectors as
shown in Fig. 3. We chose IMR90 cells because the suspension
FIG. 2. The HCF-1 VP16 interaction domain is both necessary and sufficient for chromatin association. (A) Overall structure of HCF-1. Above
and below a diagram of HCF-1 are shown the positions of (i) regions involved in association with the proteins indicated (top), (ii) structural or
sequence elements (immediately above the diagram), and (iii) functional regions (below the diagram). Within the diagram, structural and
functional features of HCF-1 are indicated from left to right as follows: the VP16 interaction or Kelch domain (gray box), the HCF-1C subunit
association element (stippled box), the region deleted by the alternative pre-mRNA splice lacking residues 382 to 450 (triangle), the basic region
(hatched box), the functional (filled triangles) and nonfunctional (open triangles) HCF-1PRO processing repeats, the acidic region (black box), the
HCF-1N subunit association element with fibronectin type 3 repeats (stippled box with arrowheads), and the carboxy-terminal NLS (black box).
VIC, VP16-induced complex. (B) Schematic of four FLAG epitope-tagged carboxy-terminal HCF-1 truncations used in this study. (C) Stable
populations of HeLa cells synthesizing either FLAG-tagged HCF-1N1011 (lanes 4 to 6), HCF-1N1011D382–450 (lanes 7 to 9), HCF-1N1011/P134S (lanes
10 to 12), or no recombinant HCF-1 protein (lanes 1 to 3) were subjected to biochemical fractionation as described in the legend to Fig. 1A. S2
(lanes 1, 4, 7, and 10), S3 (lanes 2, 5, 8, and 11), and P3 (lanes 3, 6, 9, and 12) fractions were analyzed by immunoblotting with aFLAG (upper
panel) and aHCF-1N (lower panel) antisera. The positions of endogenous HCF-1N subunits are indicated by the double dots, the positions of
FLAG-tagged recombinant HCF-1N proteins are indicated by the arrowheads, and the position of an aFLAG antiserum-cross-reacting species is
indicated by the asterisks. WT, wild type. (D) Stable populations of HeLa cells synthesizing FLAG-tagged HCF-1N380 (lanes 4 to 6) or no
recombinant HCF-1 protein (lanes 1 to 3) were subjected to biochemical fractionation and probed with the aFLAG antiserum as described for
part C. The position of the HCF-1N380 fragment is indicated by the arrowhead.
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HeLa cells used for recombinant HCF-1 synthesis are less
amenable to immunofluorescence analysis. As in HeLa cells, in
these IMR90 cells, the wild-type HCF-1N1011 (Fig. 3A, lanes 4
to 6), but not the HCF-1N1011/P134S fragment (lanes 7 to 9), is
associated with the chromatin-containing P3 fraction.
For the immunofluorescence analysis, the aFLAG anti-
serum was not sufficiently sensitive to detect the recombinant
HCF-1N proteins. We therefore used the aHCF-1N antiserum
to detect both endogenous and recombinant HCF-1N proteins
in control IMR90 cells (Fig. 3B, panels a, d, and g) or IMR90
cells synthesizing wild-type (b, e, and h) or P134S mutant (c, f,
and i) HCF-1N1011 protein. The cells were stained with DAPI
to identify nuclei (Fig. 3B, panels a to c) and with the aHCF-1N
antipeptide serum in the absence (d to f) or presence (g to i)
of specific peptide to establish the specificity of the HCF-1N
staining; indeed, the aHCF-1N antiserum produces a low level
of nonspecific staining (g to i). The control cells (Fig. 3B, panel
d) exhibit the typical predominantly nuclear immunofluores-
cence pattern of endogenous HCF-1 (11). When the wild-type
recombinant HCF-1N1011 subunit is present in the IMR90 cells,
there is an increase in nuclear staining (compare Fig. 3B,
panels d and e), whereas when the mutant HCF-1N1011/P134S
subunit is present, there is an increase in cytoplasmic staining
(compare Fig. 3B, panels d and f). These results are consistent
with nuclear localization of the wild-type but not the P134S
mutant HCF-1N1011 subunit and suggest that the predomi-
nantly cytoplasmic localization of the wild-type HCF-1N sub-
unit observed previously during transient overexpression re-
sults from the very high levels of transient HCF-1N subunit
synthesis. Perhaps an HCF-1N receptor protein(s) can bring
the HCF-1N subunit to the nucleus and chromatin and this
receptor is saturated by HCF-1N overexpression.
HCF-1 is an abundant protein. The experiments described
above suggest that HCF-1 is targeted to chromatin through
protein-protein association. Purification of HCF-1 in a previ-
ous study has suggested that it is an abundant protein (29), but
the number of molecules in a cell is unknown. Such a number
would indicate how many chromatin-bound receptor proteins
are required to recruit the HCF-1N subunit to chromatin if
they associate stoichiometrically as in the VP16-induced com-
plex. To determine the number of HCF-1 molecules in a cell,
we compared the immunoblot signal of endogenous HCF-1
from a known number of cells to that of a known concentration
of HCF-1N380 protein synthesized in E. coli (see Materials and
Methods). From the comparison, whose results are shown in
Fig. 4, we obtained a minimal estimate of the number of
HCF-1 molecules per cell by estimating that 105 cells (lane 2,
lower panel) contain 80 fmol of protein (lane 3, upper panel)
or about 5 3 105 HCF-1 molecules per HeLa cell. We esti-
mated about half that amount per IMR90 cell (data not
shown). Thus, even if our number is not absolutely precise,
HCF-1 is an abundant protein probably present at more than
100,000 molecules per HeLa or IMR90 cell. This result sug-
gests that, if only one or a few proteins target HCF-1 to chro-
matin, one or more of them should be very abundant. Alter-
natively, a large number of less abundant proteins may target
HCF-1 to chromatin.
FIG. 3. Nuclear localization of the HCF-1N1011 but not the
HCF-1N1011/P134S polypeptide. (A) Stable populations of IMR90
cells synthesizing either FLAG-tagged HCF-1N1011 (lanes 4 to 6),
HCF-1N1011/P134S (lanes 7 to 9), or no recombinant HCF-1 protein
(lanes 1 to 3) were subjected to biochemical fractionation as described
for Fig. 1A. S2 (lanes 1, 4, and 7), S3 (lanes 2, 5, and 8), and P3 (lanes
3, 6, and 9) fractions were analyzed by immunoblotting with aFLAG
antiserum. (B) The same IMR90 cell populations synthesizing FLAG-
tagged HCF-1N1011 (b, e, and h), HCF-1N1011/P134S (c, f, and i), or no
recombinant HCF-1 protein (a, d, and g) were subjected to immuno-
fluorescence analysis with purified aHCF-1N antibodies in the pres-
ence of the peptide (N18) used to raise the antiserum (g to i) or of a
nonspecific peptide (FLAG) (d to f). The nuclei in the cells shown in
images d to f were identified by staining with DAPI (a to c). WT, wild
type.
FIG. 4. HeLa cells contain over 100,000 molecules of HCF-1 per
cell. The immunoblot signal of a twofold titration of bacterially syn-
thesized HCF-1N380 protein of known molar concentration (upper
panel; the number of femtomoles of HCF-1N380 protein in each lane is
indicated) is directly compared to the immunoblot signal of a twofold
titration of HCF-1 from a known number of HeLa cells (lower panel;
the number of cells used for each lane is indicated).
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HCF-1 chromatin association is temperature sensitive in
tsBN67 cells. The tsBN67 P134S mutation prevents chromatin
association of HCF-1N subunits in HeLa cells grown at 37°C
(Fig. 2C). The same mutation causes temperature-sensitive
proliferation arrest in tsBN67 cells at 40°C. To determine
whether there is a relationship between HCF-1 chromatin as-
sociation and the temperature-sensitive defect in tsBN67 cell
proliferation, we performed biochemical fractionation on four
sets of cells: BHK21 and tsBN67 cells grown at permissive
(33.5°C) and nonpermissive (40°C) temperatures for 64 h.
To monitor the fractionation of the tsBN67 cell extracts, the
distribution of chromatin-bound ORC2 and cytosolic MEK2 in
the different fractions was assayed as shown in Fig. 5C and D.
In both cell lines and at both temperatures, ORC2 was present
exclusively in the P3 chromatin pellet (Fig. 5C, lanes 1 to 12),
indicating that the soluble fractions were not contaminated
with chromatin-associated proteins, and MEK2 was solely re-
covered in the cytosolic fraction S2 (Fig. 5D, lanes 1 to 12),
indicating that the extraction of cytosolic proteins was com-
plete.
In the same extracts, the HCF-1N and HCF-1C subunits
behaved similarly in this assay. At 33.5°C, most, albeit (unlike
with HeLa, 293, and IMR90 cells grown at 37°C) not all, of
the wild-type HCF-1 in BHK21 cells was chromatin associ-
ated (Fig. 5A and B, lanes 1 to 3). In tsBN67 cells grown at
33.5°C, about half of the HCF-1 was chromatin bound (Fig. 5A
and B, lanes 4 to 6). Thus, in contrast to the recombinant
HCF-1N1011/P134S protein in HeLa cells grown at 37°C, the
P134S mutant HCF 1 protein can bind chromatin in tsBN67
cells grown at 33.5°C. At 40°C, however, whereas the HCF-1
from BHK21 cells was still predominantly chromatin bound
(lanes 7 to 9), the HCF-1N and HCF-1C subunits from tsBN67
cells were largely absent from the chromatin-containing P3
fraction (lanes 10 to 12). Although still probably being nuclear
owing to the HCF-1C NLS, the tsBN67 HCF-1 subunits were
recovered instead in the soluble S2 fraction, probably because
soluble nuclear proteins leak out of the nucleus during the
fractionation procedure. Whatever the reason, however, these
results indicate that there is a correlation between HCF-1–
chromatin association and tsBN67 cell proliferation. Further-
more, the lack of HCF-1C subunit association with chromatin
in temperature-arrested tsBN67 cells indicates that the associ-
ation of HCF-1C subunits with chromatin is dependent on the
VP16 interaction domain of the HCF-1N subunit.
Dissociation of tsBN67 HCF-1 from chromatin at 40°C is
not immediate but precedes cell proliferation arrest. A char-
acteristic property of tsBN67 cells is that they cease to prolif-
erate at the nonpermissive temperature of 40°C after a lag of
a few cell divisions (7). To characterize the dissociation of
HCF-1 from chromatin in tsBN67 cells at 40°C, we asked how
the timing of HCF-1–chromatin dissociation correlates with
the timing of the tsBN67 cell proliferation arrest. As shown in
Fig. 6A, as with the original tsBN67 cells (7), the subclone of
tsBN67 cells used in this study (called tsBN67HR1, see Mate-
rials and Methods) stopped proliferating only after a lag of 36
to 48 h at 40°C. In contrast, BHK21 cells continued to prolif-
erate at 40°C. Remarkably, biochemical fractionation of
tsBN67 cells harvested at different time points after the shift to
40°C revealed that the P134S mutant HCF-1 subunits were still
bound to chromatin after 4 h (Fig. 6B, compare lanes 2, 4, and
6) but began to dissociate markedly from chromatin by 8 h
(lane 8) and were largely dissociated from chromatin by 16 h
(lane 10). More refined time points have indicated that com-
plete HCF-1N–chromatin dissociation occurs after about 12 to
18 h at 40°C (data not shown). In contrast, in BHK21 cells,
HCF-1 was present in the chromatin-containing P3 fraction
throughout the course of the experiment (lanes 14, 16, and 18).
Thus, in tsBN67 cells grown at 40°C, temperature-sensitive
HCF-1 dissociates from chromatin in the middle of the 36- to
48-h lag in cell proliferation arrest, preceding the arrest by
about 20 to 30 h.
Arrest of tsBN67 cell proliferation before transfer to 40°C
prevents temperature-induced dissociation of HCF-1 from
chromatin. The aforementioned results indicate that HCF-1
dissociates from chromatin in tsBN67 cells at 40°C but only
after a delay of up to 18 h. We hypothesize two mechanisms for
this delay: (i) a proliferation-independent mechanism in which
it may simply take time for the elevated temperature to disso-
ciate the temperature-sensitive HCF-1 from chromatin or (ii) a
proliferation-dependent mechanism in which proliferation at
40°C is required to dissociate the mutant HCF-1 from chro-
matin. To discriminate between these two mechanisms, we
starved tsBN67 cells of serum at 33.5°C for 24 h to arrest cell
proliferation and then transferred the arrested cells to 40°C,
maintaining the low concentration of serum, and harvested
FIG. 5. The HCF-1–chromatin association is temperature sensitive
in tsBN67 cells. BHK21 (lanes 1 to 3 and 7 to 9) and tsBN67HR1 (lanes
4 to 6 and 10 to 12) cells grown at 33.5°C (lanes 1 to 6) or 40°C (lanes
7 to 12) for 64 h were biochemically fractionated as described for Fig.
1A, and the resulting S2 (lanes 1, 4, 7, and 10), S3 (lanes 2, 5, 8, and
11), and P3 (lanes 3, 6, 9, and 12) fractions were analyzed by immu-
noblotting with aHCF-1N (A), aHCF-1C (B), aORC2 (C), and
aMEK2 (D) antisera. The protein contents of separate fractionations
were normalized by Bradford assay of each S2 fraction. The positions
of the relevant polypeptides are indicated.
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them for biochemical fractionation at different time points for
up to 30 h. At the time of transfer to 40°C, DNA content
analysis showed that the serum-starved tsBN67 cells were ar-
rested with a G1/G0 DNA content (data not shown). As shown
in Fig. 7 (upper panels), the temperature-sensitive HCF-1 did
not dissociate from chromatin in serum-starved cells through-
out the 30-h time course. In contrast, as expected, with an
asynchronously proliferating population, HCF-1 was not de-
tectable in the P3 chromatin-containing fraction by 18 h post-
shifting to 40°C (Fig. 7, lower panel). This analysis provides
two conclusions. First, because HCF-1 is bound to chromatin
in the cells arrested by serum starvation (Fig. 7, upper panel),
HCF-1 can be chromatin bound in nonproliferating cells. Sec-
ond, dissociation of the mutant HCF-1 from chromatin after
transfer to the nonpermissive temperature is proliferation de-
pendent, suggesting that HCF-1 dissociation from chromatin is
an active process during the course of tsBN67 cell prolifera-
tion.
DISCUSSION
The study presented here clarifies our understanding of
HCF-1 structure and function. They show that HCF-1—an
abundant protein—is brought to DNA, probably indirectly,
through a single structural element—its VP16 interaction do-
main—which is implicated solely in protein-protein and not
protein-DNA interactions.
That the same region of HCF-1 is involved in both VP16-
induced complex assembly and chromatin association suggests
that the VP16-induced complex represents a model for how
HCF-1 binds to chromatin naturally. Consistent with this hy-
pothesis, VP16 and the two cellular proteins that have been
shown to associate with the HCF-1 VP16 interaction domain
share the tetrapeptide motif (D/E)HXY for HCF-1 binding,
and in each case the P134S tsBN67 mutation prevents protein
association (5, 15, 17). By analogy to the VP16-induced com-
plex, Fig. 8A illustrates how we believe HCF-1 associates with
FIG. 6. Dissociation of HCF-1 from chromatin precedes tsBN67 cell proliferation arrest. (A) tsBN67HR1 cells possess temperature-induced
growth arrest characteristics similar to those of parental tsBN67 cells. BHK21 and tsBN67HR1 cells were shifted to 40°C at 0 h, harvested, and
counted at the indicated time points as described in Materials and Methods. N0, number of cells at time of transfer to 40°C; Nt, number of cells
at time of harvest. Each point is the average of results from two samples, with the deviation shown. (B) Timing of tsBN67 HCF-1P134S dissociation
from chromatin at 40°C. BHK21 (lanes 13 to 18) and tsBN67HR1 (lanes 1 to 12) cells were grown at 40°C for the indicated times and subsequently
harvested and fractionated as described for Fig. 1A. The resulting S2 (odd-numbered lanes) and P3 (even-numbered lanes) fractions were analyzed
by immunoblotting with the aHCF-1N antiserum. The positions of the HCF-1N polypeptides are indicated.
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chromatin. We hypothesize that the HCF-1 VP16 interaction
(or Kelch) domain brings HCF-1 to the DNA by contacting a
solitary DNA-bound protein, such as LZIP, or a member of a
complex of DNA-bound proteins as occurs in the VP16-in-
duced complex.
This view of HCF-1 function suggests that, by targeting
HCF-1 to specific DNA-bound regulatory proteins, the HCF-1
VP16 interaction domain is responsible for providing regula-
tory specificity. Other regions of HCF-1 are also essential,
however, for its activity. For example, the HCF-1 basic region
is necessary to promote cell proliferation (28). Because there is
no evidence from our studies that these other regions of
HCF-1 naturally bind to DNA either directly or indirectly, we
suggest that they function by associating with other non-DNA-
binding proteins (e.g., X and Y in Fig. 8A). An attractive
model is that hypothetical basic region- and HCF-1C-associ-
ated proteins are enzymes that regulate, for example, chroma-
tin structure or transcription factor function. With the HCF-1C
subunit, such a candidate effector protein is the cell cycle-
regulatory protein phosphatase 1, which can bind to the car-
boxy-terminal HCF-1C subunit (1). The basic region has not
been shown to associate with any such enzymatic activities but
instead is thought to associate with the DNA-binding proteins
GABP (26) and Sp1 (8). Because the basic region is not re-
quired for HCF-1 binding to chromatin, however, HCF-1 as-
sociation with GABP or Sp1 is probably not essential for
HCF-1 to bind to chromatin. Nevertheless, it may associate
with these two proteins once brought to the DNA through its
VP16 interaction domain or a minor population of HCF-1 not
detected in our study may associate with chromatin through
these proteins.
The findings that a single structural element of HCF-1—its
VP16 interaction domain—probably brings HCF-1 to the
DNA by stoichiometric association with a DNA-binding pro-
tein(s) and that HCF-1 is very abundant in the cell—over
100,000 copies in a typical tissue culture cell—have important
implications for our understanding of the nature of the molec-
ular target or targets of HCF-1. If the HCF-1 VP16 interaction
domain associates with a single species in the cell, as suggested
by the hypothetical a protein in Fig. 8B, this species must be
equally abundant. Proteins such as LZIP and ZF, which are
present at very low levels in tissue culture cells (14, 15), do not
satisfy this criterion. We favor a second model shown in Fig.
8C, in which HCF-1 associates with a large family of DNA-
binding proteins, of which any one member need not be abun-
dant. Such a model would be consistent with functional asso-
ciation of HCF-1 with proteins such as LZIP and ZF, which
share the short and degenerate (D/E)HXY HCF-1-binding
motif. If true, this model would suggest that HCF-1 may func-
tion like coregulatory proteins such as the coactivators p300
and CREB-binding protein and the corepressor mSin3, each of
which associates with many different DNA-binding transcrip-
tional regulators (see references 2, 6, and 24).
Whichever model is correct, the finding that the wild-type
HCF-1N subunit lacking a canonical NLS (12) is both nuclear
and chromatin bound suggests that, as with VP16, HCF-1 can
associate with its DNA-binding target protein(s) off of the
DNA and—perhaps in contrast to VP16 (see reference 12)—
bring HCF-1 to the nucleus. Consistent with this hypothesis,
the HCF-1N/P134S subunit, which fails to associate with putative
target proteins, is apparently neither chromatin bound nor
nuclear (Fig. 3). The chromatin association of wild-type
HCF-1N subunits explains why the HCF-1N1011D382–450 protein,
which lacks the NLS and does not associate with the HCF-1C
subunit, can still rescue the temperature-induced tsBN67 cell
proliferation defect (28).
Surprisingly, it is the very ability of HCF-1 to bind to chro-
matin that is temperature sensitive in the tsBN67 cell line, and
loss of chromatin association precedes temperature-induced
arrest of tsBN67 cell proliferation. These results suggest that
the temperature-sensitive cell proliferation defect of tsBN67
cells results from the loss of HCF-1P134S association with chro-
matin at the nonpermissive temperature. Both the loss of
HCF-1P134S chromatin association (Fig. 7) and the delayed loss
of cell proliferation (7), however, require cell proliferation
itself, suggesting that they are each the result of an active
growth process in the mutant tsBN67 cells.
The different time courses of HCF-1P134S dissociation from
chromatin (up to 18 h) and cell proliferation arrest (36 to 48 h)
upon transfer of tsBN67 cells to the nonpermissive tempera-
ture begin to reveal a cascade of events that leads to the arrest
of tsBN67 cell proliferation. Perhaps HCF-1 dissociation from
chromatin is delayed in asynchronous cells at the nonpermis-
sive temperature because it occurs during a particular phase of
the tsBN67 cell cycle. Such a property would explain why
proliferation is required for dissociation of HCF-1 from chro-
matin and why there is a lag of about one cell cycle (i.e., about
12 to 18 h) for full loss of HCF-1 chromatin association (Fig.
6).
The results described here, together with the role of HCF-1
in HSV-1 VP16-induced transcriptional activation, suggest that
HCF-1 is a new player in transcriptional control of cell prolif-
eration. HCF-1 may well have activities similar to those of
better-understood regulators of cell proliferation that, like
FIG. 7. tsBN67 HCF-1P134S–chromatin association is stable at the
nonpermissive temperature if tsBN67 cells are arrested before transfer
to the nonpermissive temperature. tsBN67HR1 cells were arrested by
growth in 0.25% serum at 33.5°C for 24 h, and the arrested cells were
subsequently transferred and maintained at 40°C in 0.25% serum (up-
per panels). In parallel, asynchronous tsBN67HR1 cells maintained in
10% serum were analyzed (lower panels). Cells were harvested at the
indicated times after transfer to 40°C and subjected to biochemical
fractionation as described for Fig. 1A. The resulting S2 (odd-num-
bered lanes) and P3 (even-numbered lanes) fractions were analyzed by
immunoblotting with the aHCF-1N antiserum. The positions of the
HCF-1N subunits are indicated by the dots; extra uncharacterized
bands in the serum-starved samples are indicated by asterisks.
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HCF-1, are recruited to the DNA by sequence-specific DNA-
binding proteins. Two prominent examples are the Rb protein,
which associates with E2F and recruits histone deacetylases (4,
19, 22), and mSin3, which associates with numerous DNA-
binding proteins and also recruits deacetylases (2, 24). Unlike
these complexes, however, which repress cell proliferation, a
putative HCF-1 complex promotes cell proliferation because
loss of HCF-1 function leads to an arrest of cell proliferation.
Thus, similar to its function as a viral transcriptional coactiva-
tor, HCF-1 may be a coactivator of transcription in uninfected
cells. Consistent with this hypothesis, HCF-1 can enhance tran-
scriptional activation by LZIP in transient-expression assays
(17, 18).
Although the experiments described here have revealed sim-
ilarities between HCF-1 and transcriptional regulatory pro-
teins such as Rb, the association of VP16 with HCF-1 and the
DNA tumor virus early proteins such as the adenovirus E1A
protein and simian virus 40 T-antigen proteins with Rb suggest
opposing strategies of virus-host cell interaction. The DNA
tumor virus early proteins are synthesized de novo upon infec-
tion, and by stoichiometric association they inactivate Rb to
promote infected-cell entry into S phase. In contrast, VP16 is
not synthesized de novo early in infection but instead is
brought in by the infecting virion(s), where there are only 500
to 1,000 molecules of VP16 per virion (9) compared to the
estimated 100,000 molecules of HCF-1. Thus, unlike how E1A
or T antigen inactivate the Rb protein early in infection, VP16
probably does not inactivate endogenous HCF-1 early in in-
fection and indeed may have little effect on its normal func-
tions. Thus, rather than commandeer the cell, as do E1A and
T antigen, VP16 may associate with HCF-1 surreptitiously and
use productive association as one indication for whether the
cellular environment is appropriate to promote lytic infection.
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